AASLD Announces New Co-Editors-in-Chief for HEPATOLOGY
ALEXANDRIA, Virginia — The American Association for the Study of Liver Diseases (AASLD) is pleased to announce the appointment...
AASLD & Partner Organizations Sound the Alarm: Reverse ACIP’s Hepatitis B Birth Dose Rollback Now
The American Association for the Study of Liver Diseases (AASLD) and its undersigned partner organizations, American College of...
Liver Care for Frontline Clinicians: From Assessment to Intervention
Organized by Past President, W. Ray Kim and Elizabeth Aby
Co-organizers: Mia Lozada, Hazel Domingo, Jimyeong Son, Christine...
AASLD Announces Update to Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD) Practice Guidance
New guidance provides clinicians with practical, evidence-based criteria for patient selection, comorbidity management, and...
Statement from AASLD: AASLD Acknowledges Withdrawal of Obeticholic Acid for Primary Biliary Cholangitis and Announces Upcoming Guideline Update
The American Association for the Study of Liver Diseases (AASLD) acknowledges the recent market withdrawal of obeticholic acid...
Basic Science Emerging Topic Conference: The LiverLink: Unraveling Systems Biology in Pathogenesis and Treatment of Liver Disease
Program Chairs: Savneet Kaur, PhD; Cristina Llorente, PhD; Marti Ortega Ribera, PhD
Taking place at DDW 2026, May 2-3, this two...
AASLD Announces New Practice Guideline on Treatment of Chronic Hepatitis B
The American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) are...
Digestive Disease Week® 2026
For more event information, please visit here.
Hepatitis B
AASLD develops evidence-based practice guidelines which are updated regularly by a multi-disciplinary panel of experts, including hepatologists, and include recommendations of preferred approaches to the diagnostic, therapeutic, and preventive aspects of care. AASLD also provides practice tools to assist with learning and implementing the new recommendations.